Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account

SAMHSA Finalizes Revisions for 42 CFR Part 2

On July 13, the Substance Abuse and Mental Health Services Administration (SAMHSA) finalized revisions of 42 CFR Part 2, which pertains to confidentiality of patient records related to substance use disorder (SUD). The changes specifically relate to:

  • redisclosure of SUD records;
  • consent requirements;
  • disclosures;
  • public health emergencies; and
  • research.

Part 2, a longstanding rule that dictates how to share patient data related to SUD, is intended to protect patient privacy by requiring additional consent from patients before disclosing a history of SUD.

The new changes aim to remove barriers to care coordination and allow additional information sharing for providers treating patients with SUD. SAMHSA finalized this rule to improve care coordination in the interim as the agency works on more comprehensive Part 2 flexibility mandated by Congress in the Coronavirus Aid, Relief, and Economic Security Act.

The final revisions will take effect 30 days after publication in the Federal Register.

The association will send members a detailed Action Update on the final rule in the coming days.

Contact Senior Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.

Share

About the Author

Abigail Painchaud is a policy associate at America's Essential Hospitals.

where to buy viagra
buy lasix
buy doxycycline
buy trazodone
buy metoprolol
where to buy methylprednisolone
where to buy disulfiram
canadian pharmacy
buy albuterol inhaler
buy cialis online
prednisone otc
where to buy accutane
buy abilify
buy domperidone
buy neurontin
where to buy zithromax online
buy synthroid
ivermectin otc
buy strattera online
metformin otc
clomid online
nitrofurantoin otc
online drugstore
where to buy flagyl
where to buy diflucan
mexican pharmacy
misoprostol online
discount pharmacy
citalopram online
hydroxyzine online
Previous Next
Close
Test Caption
Test Description goes like this